Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31687256 | 0.94 | TDP1 (0.43) | TDP1PAOXKDM1AHPGDDUSP3 | |
| SCHEMBL125043 | 0.83 | SMN1; SMN2 (0.48) | TDP1HPGDDUSP3ALDH1A1CYP2D6 | |
| SCHEMBL16634377 | 0.83 | PAOX (0.46) | TDP1PAOXKDM1AHPGDDUSP3 | |
| SCHEMBL2616713 | 0.82 | TDP1 (0.55) | TDP1ALDH1A1CYP2C19CYP2D6LMNA | |
| SCHEMBL9420756 | 0.81 | MEN1 (0.44) | ALDH1A1CYP3A4CYP2D6LMNAKDM4E | |
| SCHEMBL12802541 | 0.79 | TDP1 (0.44) | TDP1HPGDDUSP3ALDH1A1CYP2D6 | |
| SCHEMBL20332798 | 0.79 | TDP1 (0.56) | TDP1PAOXKDM1AHPGDDUSP3 | |
| SCHEMBL9935441 | 0.79 | TDP1 (0.33) | TDP1PAOXHPGDDUSP3ALDH1A1 | |
| SCHEMBL2616716 | 0.77 | TDP1 (0.49) | TDP1HPGDDUSP3ALDH1A1CYP2D6 | |
| SCHEMBL4401738 | 0.77 | CA12 (0.53) | TDP1PAOXKDM1AHPGDDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240425531-A1 | METHOD FOR PRODUCING CYCLIC SILAZANE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-12-26 | — | — | US | disclosed |
| EP-4410797-A1 | METHOD FOR PRODUCING CYCLIC SILAZANE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-08-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425531-A1 | METHOD FOR PRODUCING CYCLIC SILAZANE COMPOUND | CCNE1, CCNE2, CCNT1 | TDP1 4771/4885PAOX 4770/4885KDM1A 1071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.